We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+0.31%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$81.2B
AUM Growth
+$1.02B
Cap. Flow
+$958M
Cap. Flow %
1.18%
Top 10 Hldgs %
10.24%
Holding
4,189
New
550
Increased
1,503
Reduced
1,391
Closed
422

Top Buys

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$354M
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$309M
3
MSFT icon
Microsoft
MSFT
+$307M
4
ADP icon
Automatic Data Processing
ADP
+$266M
5
C icon
Citigroup
C
+$251M

Top Sells

Rank Stock Value
1
APC
Anadarko Petroleum
APC
+$567M
2
FIS icon
Fidelity National Information Services
FIS
+$410M
3
MDT icon
Medtronic
MDT
+$359M
4
AMZN icon
Amazon
AMZN
+$297M
5
ATVI
Activision Blizzard
ATVI
+$272M

Sector Composition

Rank Sector Weight
1 Technology 15.15%
2 Consumer Discretionary 12.74%
3 Healthcare 11.89%
4 Financials 8.05%
5 Industrials 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NXE icon
3676
NexGen Energy
NXE
$7.33B
$50K ﹤0.01%
38,300
-177,800
-82% -$245K
GNC
3677
DELISTED
GNC Holdings, Inc.
GNC
$50K ﹤0.01%
23,349
-468,932
-95% -$938K
LXRX icon
3678
Lexicon Pharmaceuticals
LXRX
$1.03B
$48K ﹤0.01%
15,862
-49,575
-76% -$153K
GALT icon
3679
Galectin Therapeutics
GALT
$391M
$47K ﹤0.01%
12,927
-6,571
-34% -$23.8K
PDSB icon
3680
PDS Biotechnology
PDSB
$12.1M
$46K ﹤0.01%
13,678
– –
VTVT icon
3681
vTv Therapeutics
VTVT
$134M
$46K ﹤0.01%
740
-1,148
-61% -$64.8K
CLUB
3682
DELISTED
Town Sports International Holdings, Inc.
CLUB
$46K ﹤0.01%
28,051
-19,843
-41% -$35K
TKKSW
3683
DELISTED
TKK Symphony Acquisition Corporation Warrant
TKKSW
$46K ﹤0.01%
574,288
-25,500
-4% -$2.34K
CYH icon
3684
Community Health Systems
CYH
$424M
$43K ﹤0.01%
+12,079
New +$31.5K
ECOR icon
3685
electroCore
ECOR
$87M
$43K ﹤0.01%
+1,304
New +$41.2K
ADAP
3686
DELISTED
Adaptimmune Therapeutics
ADAP
$40K ﹤0.01%
26,579
-51,411
-66% -$120K
NBRV
3687
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$40K ﹤0.01%
+79
New +$44.6K
SREV
3688
DELISTED
ServiceSource International, Inc.
SREV
$39K ﹤0.01%
44,600
+1,200
+3% +$1.09K
HL icon
3689
Hecla Mining
HL
$13.7B
$38K ﹤0.01%
+21,544
New +$38.8K
NE
3690
DELISTED
Noble Corporation
NE
$38K ﹤0.01%
29,683
-52,298
-64% -$89.3K
NGD
3691
DELISTED
New Gold Inc
NGD
$37K ﹤0.01%
36,692
+6,545
+22% +$7.96K
CLDX icon
3692
Celldex Therapeutics
CLDX
$3.19B
$36K ﹤0.01%
16,719
-2,900
-15% -$6.71K
TEN
3693
Tsakos Energy Navigation Ltd
TEN
$1.28B
$36K ﹤0.01%
2,437
-1,749
-42% -$26.9K
AUO
3694
DELISTED
AU Optronics Corp
AUO
$33K ﹤0.01%
13,215
-157,938
-92% -$414K
VBIV
3695
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$31K ﹤0.01%
+2,165
New +$45.3K
GNCA
3696
DELISTED
Genocea Biosciences, Inc.
GNCA
$31K ﹤0.01%
10,747
-10,653
-50% -$36.4K
CVIA
3697
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$30K ﹤0.01%
+14,735
New +$27.4K
SSI
3698
DELISTED
Stage Stores Inc
SSI
$30K ﹤0.01%
15,706
-3,400
-18% -$2.93K
DSKE
3699
DELISTED
Daseke, Inc. Common Stock
DSKE
$29K ﹤0.01%
+11,408
New +$32.1K
VTLE
3700
DELISTED
Vital Energy
VTLE
$28K ﹤0.01%
+580
New +$32.1K
146 147
148
149 150

Similar funds

Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

David Shaw's Q3 2019 Portfolio in Review

As of Q3 2019, David Shaw held 4,189 positions worth $81.2B, up 1.3% from $80.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

David Shaw's Q3 2019 filing shows 550 new, 1,503 increased, 1,391 reduced and 422 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 3,554,658 shares worth $310M. The largest sale was Anadarko Petroleum, an estimated $567M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • David Shaw's largest Q3 2019 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 3,554,658 shares worth $310M.
  • David Shaw added most to PayPal in Q3 2019, an estimated $354M increase.
  • David Shaw's biggest Q3 2019 reduction was Fidelity National Information Services, cutting an estimated $410M.
  • David Shaw fully exited Anadarko Petroleum in Q3 2019, selling an estimated $567M.
  • David Shaw's ten largest holdings make up 10% of its $81.2B portfolio in Q3 2019.
  • David Shaw opened 550 new positions and closed 422 in Q3 2019.
  • David Shaw's portfolio value rose 1.3% quarter-over-quarter to $81.2B.

Based on D.E. Shaw & Co's 13F filing for Q3 2019, filed 14 Nov 2019.